Each vial contains 5mg of highly pure GHRP-6 in lyophilized form.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide classified as a growth hormone secretagogue, primarily studied for its ability to stimulate the natural release of growth hormone through activation of the growth hormone secretagogue receptor (GHSR-1a), also known as the ghrelin receptor. It has been extensively investigated in research involving endocrine function, metabolism, tissue repair, and growth hormone physiology.
By binding to GHSR-1a receptors within the hypothalamus and pituitary gland, GHRP-6 promotes pulsatile secretion of endogenous growth hormone while supporting downstream production of insulin-like growth factor-1 (IGF-1). In preclinical and clinical research, these effects have been associated with enhanced protein synthesis, improved nitrogen retention, increased lean tissue development, and changes in lipid metabolism under controlled experimental conditions.
In addition to its endocrine effects, GHRP-6 is well known for its potent stimulation of appetite through activation of ghrelin-mediated signaling pathways. This characteristic has made it a valuable research compound for studies investigating energy balance, food intake, gastrointestinal physiology, and conditions involving reduced appetite or altered metabolic regulation. Experimental models have also explored its potential influence on gastric motility, tissue regeneration, and recovery following physiological stress.
Unlike direct growth hormone administration, GHRP-6 stimulates the body’s own pulsatile release of growth hormone while maintaining normal physiological feedback mechanisms. Compared with other growth hormone secretagogues, GHRP-6 has been widely recognized in research for its robust orexigenic (appetite-stimulating) effects in addition to its endocrine activity, making it useful across a broad range of metabolic and physiological investigations.
GHRP-6 remains an investigational research peptide intended exclusively for laboratory and scientific research. It has not been approved for therapeutic use in humans, and its safety and efficacy continue to be evaluated through ongoing preclinical and clinical studies.
